Inkocell Therapeutics
Lausanne
About Inkocell Therapeutics
Inkocell Therapeutics is creating a healthier tomorrow for patients with cardiac fibrosis through a life-long cure.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $189.2K
- Last round: Grant (Sep 2025)
Industries & Categories
Manufacturing, Medical, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/inkocell-therapeutics-91972 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.